Clinical trial
Post Approval Study of the remedē System
NCT03425188 is registered in ClinicalTrials.gov with Respicardia, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Approval Study of the remedē System
- Lead sponsor
- Respicardia, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 28, 2018
- Completion date
- August 4, 2020
- Enrollment
- 53 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
central sleep apnea